Skip to main content

SYSTEMATIC REVIEW article

Front. Vet. Sci.
Sec. Oncology in Veterinary Medicine
Volume 11 - 2024 | doi: 10.3389/fvets.2024.1450776

Golden era of radiosensitizers

Provisionally accepted
Jana Cizkova Jana Cizkova 1Ondrej Jan Dolezal Ondrej Jan Dolezal 1Vojtech Buchta Vojtech Buchta 2Jan Pospichal Jan Pospichal 2Vit Blanar Vit Blanar 2Zuzana Šinkorová Zuzana Šinkorová 1Anna Carrillo Anna Carrillo 1*
  • 1 Department of Radiobiology, Military Faculty of Medicine, University of Defence, Hradec Kralove, Czechia
  • 2 Department of Clinical Subspecialities, Faculty of Health Studies, University of Pardubice, Pardubice, Pardubice, Czechia

The final, formatted version of the article will be published soon.

    The past 30 years have brought undeniable progress in medicine, biology, physics, and research.Knowledge as to the nature of the human body, diseases, and disorders has been constantly improving, and the same is true regarding their treatment and diagnosis. One of the greatest advances in recent years has been the introduction of nanoparticles into medicine. Nanoparticles (NPs) refer to a material at a nanometer scale (0.1-100 nm) with features (specific physical, chemical, and biological properties) that are broadly and increasingly used in the medical field.Their applications in cancer treatment and radiotherapy seem particularly attractive. In this field, inorganic/metal NPs with high atomic number Z have been employed mainly due to their ability to enhance ionizing radiation's photoelectric and Compton effects and thereby to increase the efficacy of conventional radiation therapy. The improvement enabled by NPs relates to their enhanced permeation ability and longer retention effect in tumor cells, capacity to reduce toxicity of commercially available cancer drugs through advanced NPs drug delivery systems, radiation sensitizers of tumors, or enhancers of radiation doses to tumors. Advanced options according to size, core, and surface modification allow even such multimodal approaches in therapy as nanotheranostics or combined treatments. The current state of knowledge emphasizes the role of gold nanoparticles (AuNPs) in sensitizing tumors to radiation. We have reviewed AuNPs and their radiosensitizing power during radiation treatment. Our results are divided into groups based on AuNPs surface modification and/or core structure design. This paper provides a complete summary of the in vivo sensitizing effect of AuNPs, surface-modified AuNPs, and AuNPs combined with different elements, providing evidence for further successful veterinarian and clinical implementation.

    Keywords: gold nanoparticles, Radiotherapy, Radiosensitizers, in vivo, tumor sensitizing

    Received: 18 Jun 2024; Accepted: 21 Nov 2024.

    Copyright: © 2024 Cizkova, Dolezal, Buchta, Pospichal, Blanar, Šinkorová and Carrillo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Anna Carrillo, Department of Radiobiology, Military Faculty of Medicine, University of Defence, Hradec Kralove, Czechia

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.